MYGOGENESIS Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for MYGOGENESIS with the United States Patent and Trademark Office. The USPTO has given the MYGOGENESIS trademark a serial number of 98788531. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 2, 2025. This trademark is owned by Mygogenesis LLC. The MYGOGENESIS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Production in the fields of cellular medicine, genetic medicine, and regenerative medicine being custom manufacture of pharmaceuticals by pharmaceutical compounders

Scientific research services in the fields of cellular medicine, genetic medicine, and regenerative medicine; Laboratory research services in the fields of cellular medicine, genetic medicine, and regenerative medicine; Engineering services in the field of human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, discovery of drugs, and development of drugs; Biological cloning services, namely, creating zygotic clones
mygogenesis

General Information


Serial Number98788531
Word MarkMYGOGENESIS
Filing DateMonday, October 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Goods and ServicesProduction in the fields of cellular medicine, genetic medicine, and regenerative medicine being custom manufacture of pharmaceuticals by pharmaceutical compounders
Pseudo MarkNULL
Pseudo MarkMYGOTIC GENESIS
Goods and ServicesScientific research services in the fields of cellular medicine, genetic medicine, and regenerative medicine; Laboratory research services in the fields of cellular medicine, genetic medicine, and regenerative medicine; Engineering services in the field of human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, discovery of drugs, and development of drugs; Biological cloning services, namely, creating zygotic clones

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSaturday, August 2, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMygogenesis LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGermantown, MD 20874

Party NameMygogenesis LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGermantown, MD 20874

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Monday, October 7, 2024APPLICATION FILING RECEIPT MAILED
Monday, May 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 13, 2025NON-FINAL ACTION E-MAILED
Saturday, August 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 6, 2025ASSIGNED TO EXAMINER
Monday, August 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED